Cite
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
MLA
Borchmann, Peter, et al. “PET-Guided Treatment in Patients with Advanced-Stage Hodgkin’s Lymphoma (HD18): Final Results of an Open-Label, International, Randomised Phase 3 Trial by the German Hodgkin Study Group.” Lancet, vol. 390, no. 10114, Dec. 2017, pp. 2790–802. EBSCOhost, https://doi.org/10.1016/S0140-6736(17)32134-7.
APA
Borchmann, P., Goergen, H., Kobe, C., Lohri, A., Greil, R., Eichenauer, D. A., MZijlstra, J., Markova, J., Meissner, J., Feuring-Buske, M., Hüttmann, A., Dierlamm, J., Soekler, M., Beck, H.-J., Willenbacher, W., Ludwig, W.-D., Pabst, T., Topp, M. S., Hitz, F., & Bentz, M. (2017). PET-guided treatment in patients with advanced-stage Hodgkin’s lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group. Lancet, 390(10114), 2790–2802. https://doi.org/10.1016/S0140-6736(17)32134-7
Chicago
Borchmann, Peter, Helen Goergen, Carsten Kobe, Andreas Lohri, Richard Greil, Dennis A. Eichenauer, Josée MZijlstra, et al. 2017. “PET-Guided Treatment in Patients with Advanced-Stage Hodgkin’s Lymphoma (HD18): Final Results of an Open-Label, International, Randomised Phase 3 Trial by the German Hodgkin Study Group.” Lancet 390 (10114): 2790–2802. doi:10.1016/S0140-6736(17)32134-7.